Brunswick Corporation logo BC - Brunswick Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 22
HOLD 9
SELL 0
STRONG
SELL
0
| PRICE TARGET: $91.50 DETAILS
HIGH: $94.00
LOW: $86.00
MEDIAN: $93.00
CONSENSUS: $91.50
UPSIDE: 27.17%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Overvalued Strong
Trading 119.5% above fair value
Current Price $71.95
Bear Case $23.84 66.9% downside ($23.84 - $71.95) / $71.95 = -66.9% $5.96 × 4x
Fair Value $32.78 54.4% downside ($32.78 - $71.95) / $71.95 = -54.4% $5.96 × 6x
Bull Case $41.72 42.0% downside ($41.72 - $71.95) / $71.95 = -42.0% $5.96 × 7x

Adjust Assumptions

5.5x
5.96$

Key Value Driver

Through-cycle normalized EPS ($5.96)

Implied Market Multiple 12.1x

Plain-Language Summary

Using 7-year normalized EPS of $5.96 at a 6x cycle multiple, the base-case value is $32.78 per share. P/TBV cross-check: 52.2x.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (31 analysts) $91.50
Analyst Range $86.00 – $94.00
Divergence from AlphaVal 64%

Warnings

This company has a built-in lending arm whose debt is mixed in with the main business. We capped the debt adjustment to avoid overstating what the core business owes.
Price-to-book value of 52.2x is above the normal range for this type of business (0.7x-2.0x). The stock may already price in a strong cycle.
Wall Street's average price target is $91.50 (from 31 analysts). Our estimate is 64% below the consensus -- consider that gap carefully.

Key Risks

  • Standard 10-year DCF produces unreliable terminal values for cyclicals
  • 'Cheap' P/E at cycle peak is the most common value trap — normalize first
  • Captive finance subsidiaries have different risk profiles from manufacturing